CVRx Reports First Quarter 2026 Financial and Operating Results
Stocks in this Quantisnow insightHealth Care
Historical context for CVRX
Across the 14 sessions after earlier CVRX headlines, the stock closed higher 6 times and lower 8 times, with a median move of 3.0% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | CVRX | SPY |
|---|---|---|---|
| May 5, 2026 | CVRx Announces First Patient Enrollment in BENEFIT-HF, a Landmark Heart Failure Trial Evaluating Barostim in Significantly Expanded Population | -3.8% | +0.8% |
| Apr 28, 2026 | CVRx to Report First Quarter 2026 Financial and Operating Results and Host Conference Call on May 11, 2026 | -2.2% | -0.5% |
| Apr 13, 2026 | CVRx Reports Preliminary First Quarter 2026 Financial Results | +9.2% | +1.0% |
| Mar 2, 2026 | CVRx Announces Late-Breaking Data and Scientific Presentations Highlighting Barostim Outcomes at the THT 2026 Annual Meeting | +0.7% | +0.1% |
| Feb 13, 2026 | CVRx Reports Fourth Quarter and Full Year 2025 Financial and Operating Results | -13.0% | +0.1% |
| Jan 30, 2026 | CVRx to Report Fourth Quarter 2025 Financial and Operating Results and Host Conference Call on February 12, 2026 | -2.3% | -0.3% |
Quantisnow market dataNASDAQ
CVRX
CVRx Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- Listed since
- 2021
Get push alerts for CVRX
Full CVRX profile on Quantisnow Follow CVRX and get a push notification the moment its next story breaks.